Avalo Therapeutics (AVTX) Shares Outstanding (2014 - 2026)
Avalo Therapeutics' Shares Outstanding came in at 43.6 million for Q2 2026, up 302.6% from 10.83 million a year earlier and up 225.3% from the prior quarter.
Powered by 
Analysis
Avalo Therapeutics (AVTX) Shares Outstanding (2014 - 2026) Analysis & Trends
For FY2025, Avalo Therapeutics' Shares Outstanding was 13.4 million, up 202.9% from FY2024.
- Shares Outstanding carries a five-year compound annual growth rate of 255.4% (FY2020 to FY2025).
- Going back by year, Shares Outstanding was 4.43 million in FY2024, 277,727 in FY2023 (+607.9%), 39,233 in FY2022 (+8.3%) and 36,219 in FY2021 (+53.2%).
- The Q2 2026 figure represents the highest quarterly Shares Outstanding in data going back to Q3 2014.
- Year-over-year, Shares Outstanding has increased for five consecutive quarters, with growth averaging 326.5% over the last five quarters.
- Over the past five years, the year-over-year growth in Shares Outstanding ranged from 8.3% (Q4 2022) to 947.2% (Q2 2025).
- Business Quant data shows AVTX's Shares Outstanding at 13.4 million (Q1 2026), 13.4 million (Q4 2025) and 14 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 891.90 Mn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 2.41 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 1.77 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 2.47 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | 1.94 Bn |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 1.55 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 541.00 Mn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 1.24 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 5.70 Bn |
| 10 | Avalo Therapeutics | 386.09 Mn | -587.48 Mn | - | 55.06 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 55.06 Mn |
| Jun 30, 2026 | 43.60 Mn |
| Mar 31, 2026 | 20.11 Mn |
| Dec 31, 2025 | 13.40 Mn |
| Sep 30, 2025 | 14.00 Mn |
| Jun 30, 2025 | 10.83 Mn |
| Mar 31, 2025 | 10.51 Mn |
| Dec 31, 2024 | 4.43 Mn |
| Sep 30, 2024 | 5.55 Mn |
| Jun 30, 2024 | 1.03 Mn |
| Mar 31, 2024 | 859,381.00 |
| Dec 31, 2023 | 46.76 Mn |
| Sep 30, 2023 | 46.76 Mn |
| Jun 30, 2023 | 13.97 Mn |
| Mar 31, 2023 | 11.72 Mn |
| Dec 31, 2022 | 9.41 Mn |
| Sep 30, 2022 | 9.41 Mn |
| Jun 30, 2022 | 9.40 Mn |
| Mar 31, 2022 | 9.40 Mn |
| Dec 31, 2021 | 8.69 Mn |
API Access
Avalo Therapeutics Shares Outstanding API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding&ticker=AVTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding", "ticker": "AVTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding&ticker=AVTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();